Health ❯ Healthcare

Regulation

FDA Drug Safety Drug Approval Pharmaceuticals Drug Regulation Product Safety Professional Standards Health Authorities Pharmaceutical Regulation General Medical Council

Mexico Renews Warning as Counterfeit GLP-1 Weight-Loss Drugs Spread Worldwide

Some seized products contained insulin or bacteria, creating risks of severe drops in blood sugar or serious infection.

FDA Proposes ‘Plausible Mechanism’ Pathway for Individualized Rare-Disease Therapies

UK Regulator Flags Rare Pancreatitis, Including Deaths, Tied to Wegovy and Mounjaro

Coroner Issues Safety Warning on Doulas After Baby’s Death

ANMAT Revokes 54 Distributors’ Licenses, Deregisters Two Labs, Restricts Dental y Mediquil Sales

FDA Orders Online Supplements Pulled Over Hidden Drugs and Allergens

FDA Eases CMC Rules for Cell and Gene Therapies to Speed Development

FDA Eases Oversight of Wearables and Clinical Decision Support in Final Guidance

NHS and MHRA Warn Against Social Media Weight‑Loss Jabs After Poll Flags Buyer Interest

MHRA Issues New Year Warning Against Buying Weight-Loss Jabs From Unregulated Sellers

Anvisa Bans Sales and Advertising of Raia Drogasil’s Needs and Bwell Medicines

MHRA Opens Public Call for Evidence on Regulating AI in NHS Care

FDA Installs Tracy Beth Hoeg as Acting CDER Director as Pazdur Files Retirement

Anvisa Prohibits Unregistered GLP-1 'Weight-Loss Pens' in Brazil

GMC Warns of 'Huge Holes' as Record Numbers of Overseas Doctors Leave the NHS

FDA Names Richard Pazdur to Lead Drug Review Center

Radiographers Warn High‑Street Baby Scan Clinics Put Mothers and Babies at Risk

China Enforces Credential Rule for Influencers on Health, Law, Finance and Education

MHRA Names Seven Manufacturers for Phase Two of AI Airlock to Trial Clinical AI Tools

Doctors and Pharmacists Demand Crackdown on Telehealth Cannabis Prescribing as AHPRA Tightens Rules